Dyne Therapeutics

📍 Waltham, United States🗓 Founded 2018👥 134 employees
Biotechnology🌐 dyne-tx.com
Website LinkedIn
Dyne Therapeutics is a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases. With its proprietary FORCE™ platform, Dyne is developing modern oligonucleotide therapeutics that are designed to overcome limitations in delivery to muscle tissue. Dyne has a broad pipeline for serious muscle diseases, including clinical programs for myotonic dystrophy type 1 (DM1) and Duchenne muscular dystrophy (DMD) and a preclinical program for facioscapulohumeral muscular dystrophy (FSHD). For more information, please visit https://www.dyne-tx.com.
0
Total investors
0
Early stage
0
Mid stage
0
Late stage
2018
Founded

Investors

0 investors
All
Early stage
Mid stage
Late stage
No investors in this category
Frequently asked questions
When was Dyne Therapeutics founded?
Dyne Therapeutics was founded in 2018.
What industry is Dyne Therapeutics in?
Dyne Therapeutics operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Dyne Therapeutics based?
Dyne Therapeutics is headquartered in Waltham, United States.